Zevra Therapeutics Inc — Balance Sheet (NASDAQ:ZVRA) | MetaTrader

Open full chart

Financials

Overview 声明 Statistics Dividends

Quarterly Annual

Total assets 11.21 M132.94 M115.53 M172.33 M178.13 M Total liabilities 77.62 M5.82 M29.72 M110.46 M138.46 M Total equity 66.41 M127.12 M85.81 M61.86 M39.67 M Total liabilities & shareholders' equities 11.21 M132.94 M115.53 M172.33 M178.13 M Total debt ————— Net debt —————

新闻

Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates

Ironwood Pharmaceuticals (IRWD) Reports Q4 Loss, Lags Revenue Estimates

尼尔·F·麦克法兰，Zevra Therapeutics总裁，出售价值12.5万美元股票

Neil F. McFarlane, Zevra Therapeutics president, sells $125k in shares

Zevra Therapeutics首席医疗官Quartel出售价值4万美元股票

Zevra首席商务官Joshua Schafer出售价值$29,800的ZVRA股票

Zevra Therapeutics CMO Quartel sells $40k in shares

Schafer Joshua, CCO of Zevra, sells $29,800 in ZVRA stock

Zevra Therapeutics首席执行官McFarlane出售价值85.3万美元股票

Zevra Therapeutics CEO McFarlane sells $853k in shares

Zevra Therapeutics, Inc. (ZVRA) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Zevra Stock: Asymmetric Risk-Reward Setup In Ultra-Rare Disease Market (ZVRA)